MedPath
HSA Approval

KETAMINE HAMELN INJECTION 50 MG/ML

SIN15402P

KETAMINE HAMELN INJECTION 50 MG/ML

KETAMINE HAMELN INJECTION 50 MG/ML

January 9, 2018

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

N01AX03

ketamine

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

Siegfried Hameln GmbH

Active Ingredients

Ketamine hydrochloride 57.7 mg/ml eqv to Ketamine 50mg/ml

50 MG

Ketamine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

KETAMINE HAMELN INJECTION 50 MG/ML - HSA Approval | MedPath